Davide Sartini

21PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)NanomaterialsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 03, 2026
Upregulation of paraoxonase-2 enzyme in human osteosarcoma and its involvement in mechanisms promoting the aggressive behavior of tumor cells.

|Jun 25, 2026
Xenobiotic Sulforaphane in Head and Neck Cancer: Beyond the Nrf2 Pathway.

|Mar 24, 2026
Short and Long Non-Coding RNAs in Renal Cell Carcinoma.

Monia Cecati, Valentina Pozzi, Valentina Schiavoni

|Jan 21, 2026
Cisplatin as a Xenobiotic Agent: Molecular Mechanisms of Actions and Clinical Applications in Oncology.

Monia Cecati, Valentina Pozzi, Veronica Pompei

|Nov 27, 2025
Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Enzyme for the Treatment of Osteosarcoma and Merkel Cell Carcinoma: Potential for the Development of a Targeted Therapeutic Strategy.

Veronica Pompei, Monia Cecati, Emma Nicol Serritelli

|May 06, 2024
Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines.

Valentina Schiavoni, Monica Emanuelli, Roberto Campagna

Pageof 4

Frequent Collaborators

14 joint publications

Roberto Campagna

12 joint publications

Valentina Pozzi

9 joint publications

Eleonora Salvolini

6 joint publications

Monica Emanuelli